Contact PD/PI: Murphy, Timothy F Buffalo Clinical and Translational Research Center The Buffalo Translational Consortium (BTC), which includes 12 major academic, research and healthcare institutions and 5 influential community partners in our region, have embarked on a comprehensive strategic plan to build a strong foundation for clinical and translational research in response to our community needs. Buffalo is the second most populous city in New York State and has a rich cultural history. The distribution of underrepresented minorities who experience health disparities in Buffalo in 2015 (50%) parallels that projected for the US in 2050, making Buffalo a microcosm of what the US will look like in 35 years. The vision for our CTSA hub is to develop, test and share novel approaches to improve health and reduce health disparities in our community, which represents a ?population of the future?. Improving health in our community and the nation will require innovative research across the full T1 through T4 translational spectrum. In 2012, the University at Buffalo opened the new 170,000 ft2 state-of-the-art Clinical and Translational Research Center (CTRC) devoted entirely to clinical and translational research. The CTRC provides a centralized facility, including translational research laboratories, a clinical research center, an imaging center, a lab animal facility and a biorepository. The CTRC and other enormous BTC investments to build a 21st century Academic Health Center creates a setting for a CTSA to provide the key piece to transform our capacity to bring discoveries in the laboratory, the clinic and the community to benefit individual and public health by sharing expertise and innovative approaches to translational science as part of the national consortium. We will bring strengths to the CTSA consortium, including developing novel health informatics tools, leveraging our strength as a leading center on research in standards and ontologies; new approaches to community-based research developed with our community; testing and disseminating ontology-based methods to share translational image data; and one of the few full service Drug Development Services in the consortium. With a CTSA we will 1) accelerate the development, implementation and dissemination of new healthcare interventions and their translation into the community through innovative research across the T1 through T4 spectrum, 2) train and develop an excellent and diverse workforce to ensure that translational researchers and their teams have the skills and knowledge to advance translation of discoveries, 3) build a translational science pipeline that integrates data from multiple sources and combines data analysis methods to discover diagnostic, therapeutic and preventive interventions, and 4) streamline clinical research processes with a focus on quality to enhance recruitment of special populations across the lifespan and groups with health disparities, and accelerate multi-site clinical trial initiation. Building on our unique strengths will enhance both our local and national CTSA network capacity through collaboration and sharing expertise and resources. Project Summary/Abstract Page 272 Contact PD/PI: Murphy, Timothy F Buffalo Clinical and Translational Research Center

Public Health Relevance

The Buffalo Clinical and Translational Research Center is the coordinating center of the Buffalo Translational Consortium which will perform innovative research across the T1 through T4 translational spectrum to improve health in our community and the nation. We have brought together the region's premier research, educational and clinical institutions with influential community partners to create a shared environment to bring discoveries in the laboratory, clinic and community to benefit individual and public health. Project Narrative Page 273

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001412-03
Application #
9258515
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Rosemond, Erica
Project Start
2015-08-12
Project End
2019-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
$3,039,817
Indirect Cost
$1,104,676
Name
State University of New York at Buffalo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
038633251
City
Amherst
State
NY
Country
United States
Zip Code
14228
Welliver, R Ross; Polanco, Jessie J; Seidman, Richard A et al. (2018) Muscarinic receptor M3R signaling prevents efficient remyelination by human and mouse oligodendrocyte progenitor cells. J Neurosci :
Jacobs, David M; Ochs-Balcom, Heather M; Zhao, Jiwei et al. (2018) Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease. J Clin Microbiol 56:
Jacobs, David M; Noyes, Katia; Zhao, Jiwei et al. (2018) Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database. Ann Am Thorac Soc 15:837-845
Langkammer, Christian; Schweser, Ferdinand; Shmueli, Karin et al. (2018) Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge. Magn Reson Med 79:1661-1673
Bailey, Daniel C; Buckley, Brian P; Chernov, Mikhail V et al. (2018) Development of a High-Throughput Biochemical Assay to Screen for Inhibitors of Aerobactin Synthetase IucA. SLAS Discov 23:1070-1082
Gallo, Mary C; Kirkham, Charmaine; Eng, Samantha et al. (2018) Changes in IgA Protease Expression Are Conferred by Changes in Genomes during Persistent Infection by Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Infect Immun 86:
Curtis, Anne B; Karki, Roshan; Hattoum, Alexander et al. (2018) Arrhythmias in Patients ?80 Years of Age: Pathophysiology, Management, and Outcomes. J Am Coll Cardiol 71:2041-2057
Weil, Brian R; Suzuki, Gen; Young, Rebeccah F et al. (2018) Troponin Release and Reversible Left Ventricular Dysfunction After Transient Pressure Overload. J Am Coll Cardiol 71:2906-2916
Guo, Xiaojuan; Chen, Xushen; Wang, Jie et al. (2018) Multi-generational impacts of arsenic exposure on genome-wide DNA methylation and the implications for arsenic-induced skin lesions. Environ Int 119:250-263
Chang, Yu-Ping (2018) Factors associated with prescription opioid misuse in adults aged 50 or older. Nurs Outlook 66:112-120

Showing the most recent 10 out of 238 publications